Purification of active matrix metalloproteinase catalytic domains and its use for screening of specific stromelysin-3 inhibitors

Protein Expression and Purification

Volumn 16, Issue 1, 1999, Pages 76-83

  Kannan, Rama ^a   Ruff, Marc ^a   Kochins, John G ^b   Manly, Susan P ^b   Stoll, Isabelle ^a   El Fahime, Mostafa ^a   Noël, Agnès ^c   Foidart, Jean Michel ^c   Rio, Marie Christine ^a   Dive, Vincent ^d   Basset, Paul ^a  

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b BRISTOL MYERS SQUIBB PHARMACEUTICAL RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF LIÈGE   (Belgium)

^d DIF   (France)

Author keywords

Cephalosporin; Matrix metalloproteinase inhibitors; Stromelysin 3; 1 Proteinase inhibitor

Indexed keywords

ANTIBIOTIC ANALYSIS; CEPHALOSPORIN; ENZYME ASSAY; ENZYME INHIBITOR; ENZYME PURIFICATION; METALLOPROTEINASE; STROMELYSIN 3;

BACTERIA (MICROORGANISMS);

EID: 0033152673     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1006/prep.1999.1068     Document Type: Article

References (28)

1. Stöcker, W., and Bode, W. (1995) Structural features of a super-family of zinc-endopeptidases: The metzincins. Curr. Opin. Struct Biol. 5, 383-390.
2. Coussens, L. M., and Werb, Z. (1996) Matrix metalloproteinases and the development of cancer. Chem. Biol. 3, 895-904.
3. Basset, P., Okada, A., Chenard, M. P., Kannan, R., Stoll, I., Anglard, P., Bellocq, J. P., and Rio, M. C. (1997) Matrix metalloproteinases as stromal effectors of human carcinoma progression: Therapeutic implications. Matrix Biol. 15, 535-541.
4. Gomez, D. E., Alonso, D. F., Yoshiji, H., and Thorgeirsson, U. P. (1997) Tissue inhibitors of metalloproteinases: Structure, regulation and biological functions. Eur. J. Cell. Biol. 74, 111-122.
5. Imren, S., Kohn, D. B., Shimada, H., Blavier, L., and DeClerck, Y. A. (1996) Overexpression of tissue inhibitor of metalloproteinases-2 by retroviral-mediated gene transfer in vivo inhibits tumor growth and invasion. Cancer Res. 56, 2891-2895.
6. Beckett, R. P. (1996) Recent advances in the field of matrix metalloproteinase inhibitors. Exp. Opin. Ther. Patents 6, 1305-1315.
7. Stetler Stevenson, W. G., Hewitt, R., and Corcoran, M. (1996) Matrix metalloproteinases and tumor invasion: From correlation and causality to the clinic. Semin. Cancer Biol. 7, 147-154.
8. Rasmussen, H. S., and McCann, P. P. (1997) Matrix metalloproteinase inhibition as a novel anticancer strategy: A review with a special focus on batimastat and marimastat. Pharmacol. Ther. 75, 69-75.
9. Rouyer, N., Wolf, C., Chenard, M. P., Rio, M. C., Chambon, P., Bellocq, J. P., and Basset, P. (1995) Stromelysin-3 gene expression in human cancer: An overview. Invasion Metastasis 14, 269-275.
10. Chenard, M. P., O'Siorain, L., Shering, S., Rouyer, N., Lutz, Y., Wolf, C., Basset, P., Bellocq, J. P., and Duffy, M. J. (1996) High levels of stromelysin-3 correlate with poor prognosis in patients with breast carcinoma. Int. J. Cancer 69, 448-451.
11. Masson, R., Lefebvre, O., Noël, A., El Fahime, M., Chenard, M.-P., Wendling, C., Kebers, F., LeMeur, M., Dierich, A., Foidart, J.-M., Basset, P., and Rio, M.-C. (1998) In vivo evidence that stromelysin-3 metalloproteinase contributes in a paracrine manner to epithelial cell malignancy. J. Cell Biol. 140, 1535-1541.
12. Nagase, H. (1997) Activation mechanisms of matrix metalloproteinases. Biol. Chem. 378, 151-160.
13. Mast, A. E., Enghild, J. J., Nagase, H., Suzuki, K., Pizzo, S. V., and Salvesen, G. (1991) Kinetics and physiological relevance of the inactivation of alpha 1-proteinase inhibitor, alpha 1-antichymotrypsin, and antithrombin III by matrix metalloproteinases-1 (tissue collagenase), -2 (72 -kDa gelatinase/type IV collagenase), and -3 (stromelysin). J. Biol. Chem. 266, 15810-15816.
14. Pei, D., Majumdar, G., and Weiss, S. J. (1994) Hydrolytic inactivation of a breast carcinoma cell-derived serpin by human stromelysin-3. J. Biol. Chem. 269, 25849-25855.
15. Noël, A., Santavicca, M., Stoll, I., L'Hoir, C., Staub, A., Murphy, G., Rio, M.-C., and Basset, P. (1995) Identification of structural determinants controlling human and mouse stromelysin-3 proteolytic activities. J. Biol. Chem. 270, 22866-22822.
16. Wolf, C., Rouyer, N., Lutz, Y., Adida, C., Loriot, M., Bellocq, J. P., Chambon, P., and Basset, P. (1993) Stromelysin 3 belongs to a subgroup of proteinases expressed in breast carcinoma fibroblastic cells and possibly implicated in tumor progression. Proc. Natl. Acad. Sci. USA 90, 1843-1847.
17. Okada, A., Bellocq, J.-P., Rouyer, N., Chenard, M.-P., Rio, M.-C., Chambon, P., and Basset, P. (1995) Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. Proc. Natl. Acad. Sci. USA 92, 2730-2734.
18. 1 positions. J. Biol. Chem. 273, 2763-2768.
19. DeClerck, Y. A., Yean, T. D., Lu, H. S., Ting, J., and Langley, K. E. (1991) Inhibition of autoproteolytic activation of interstitial procollagenase by recombinant metalloproteinase inhibitor MI/TIMP-2. J. Biol. Chem. 266, 3893-3899.
20. Knight, G. C., Willenbrock, F., and Murphy, G. (1992) A novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases. FEBS Lett. 3, 263-266.
21. Nagase, H. (1995) Human stromelysins 1 and 2. Methods Enzymol. 248, 449-470.
22. MacDougall, J. R., and Matrisian, L. M. (1995) Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer Metast Rev. 14, 351-362.
23. Basset, P., Bellocq, J.-P., Lefebvre, O., Noël, A., Chenard, M.-P., Wolf, C., Anglard, P., and Rio, M.-C. (1997) Stromelysin-3: A paradigm for stroma-derived factors implicated in cancer progression. Crit. Rev. Oncol. Hematol. 26, 43-53.
24. Barbacid, M. D.-M., Fernandez-Resa, P., Buesa, J.-M., Marquez, G., Aracil, M., Quesada, A. R., and Mira, E. (1998) Expression and purification of human stromelysin 1 and 3 from baculovirus-infected insect cells. Protein Express. Purif. 13, 243-250.
25. Santavirta, S., Takagi, M., Konttinen, Y. T., Sorsa, T., and Suda, A. (1996) Inhibitory effect of cephalothin on matrix metalloproteinase activity around loose hip prostheses. Antimicrob. Agents Chemother. 40, 244-246.
26. Thompson, R. W., and Parks, W. C. (1996) Role of matrix metalloproteinases in abdominal aortic aneurysms. Ann. N. Y. Acad. Sci. 800, 157-174.
27. Grange, J. J., Davis, V., and Baxter, B. T. (1997) Pathogenesis of abdominal aortic aneurysm: An update and look toward the future. Cardivasc. Surg. 5, 256-265.
28. Hodgson, J. (1995) Remodeling MMPIs. Bio/Technology 13, 554-557.